A rapid method for detection of respiratory syncytial virus (RSV) samples from which other respiratory viruses were isolated. The speed, sensitivity (94.6%), and specificity (>97%) of the RT-PCR assay suggest that this technique could be useful for rapid detection of RSV in clinical samples.
Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory tract infections in humans, with infants and young children being particularly susceptible. Traditionally, diagnosis of RSV infection has centered on the "gold standard" technique of culture of the virus from nasopharyngeal secretions. However, cell culture methods are generally slow, often taking up to a week before a result is available, and sensitivity may be affected by the lability of RSV (9) . The availability of antiviral therapeutic agents effective against RSV and the need to minimize the risk of cross-infection have prompted the development of immunochemical techniques for direct detection of virus, such as direct immunofluorescence and more recently, antigen-capture enzyme immunoassays (EIA) (9) . These methods are much faster than culture, giving results on the same day, but the sensitivity and to a lesser extent the specificity appear to vary considerably (4, 5, (7) (8) (9) ). An alternative diagnostic approach has involved improvement of the speed of RSV culture techniques by the use of immunochemical methods to detect early virus infection of cell cultures, rather than waiting for a cytopathic effect to become apparent (6) . However, such tests still take up to 3 days.
A study carried out at the Adelaide Children's Hospital identified RSV as the single most common cause of nosocomial pediatric respiratory infections during the winter months (2) . The results of this study also suggested that the cross-infection rate might be reduced further by improving the sensitivity and specificity of rapid RSV detection assays.
We have developed a rapid method based on reverse transcription (RT) and amplification of viral nucleic acid sequences by the polymerase chain reaction (PCR). This procedure was tested on nasopharyngeal aspirates from children with suspected respiratory infections.
MATERIALS AND METHODS
Patient samples. Nasopharyngeal aspirates (NPAs) were collected from 202 children aged 1 month to 6 years (median age, 14 months) with suspected respiratory infections. The suction catheter was flushed by aspiration of 2 ml of viral transport medium into a specimen trap. A 0.5-ml portion of each specimen was withdrawn and stored at -70°C for subsequent analysis by RT-PCR. The remainder was immediately refrigerated and transported to a nearby central pathology laboratory which provides routine diagnostic virology services to was also added to each tube, and the tubes were subjected to 35 amplification cycles, each cycle consisting of 1.5-min denaturation, annealing, and elongation steps at temperatures of 94, 47, and 72°C, respectively. The sequences of the two primers used were 5'-TTAACCAGCAAAGTGTlTA GA-3' and 5'-TITTGTTATAGGCATATCATTG-3'. These primers define a 243-bp segment of the RSV genome encoding the Fl subunit of the fusion (F) protein, and the sequences to which the primers anneal are identical for both the A and B subgroups of RSV (3). The 243-bp amplified product was detected by electrophoresing 20-pI aliquots through 2% agarose gels in the presence of ethidium bromide for approximately 30 min at 10 V/cm and photographing the gels under UV illumination.
RESULTS
Specificity and sensitivity of RT-PCR for RSV. The oligonucleotide primers used in the RT-PCR assay were chosen on the basis of previously published sequence data, which indicated that the regions to which these primers anneal are identical for both the A and B subgroups of RSV (3) . As an initial check on the specificity of these primers for RSV, the oligonucleotides were analyzed for homology with all sequences stored in the GenBank data base (version R64.0) using the DNASIS software package (Pharmacia LKB Biotechnology, Uppsala, Sweden). No homologies likely to result in spurious annealing were detected. Specificity was then examined directly by subjecting cell culture extracts infected with either RSV (Long strain) or clinical isolates of adenovirus, parainfluenza virus type 1, parainfluenza virus type 3, influenza A virus, or influenza B virus to RT-PCR (Fig. 1) . A PCR product of the expected size (243 bp) was observed for RSV but not for any of the other virus cultures.
The sensitivity of the RT-PCR assay was examined by analyzing serial 10-fold dilutions (10°-to 106-fold) of an RSV-infected HEp-2 lysate. The virus titer of this lysate was approximately 8 x i07 TCID50s per ml. A distinct PCR product was detected when 100-pA aliquots diluted up to 105-fold were tested, and a band was faintly discernible in the reaction from the 106-fold dilution (Fig. 2) 3 years. Of these samples, 11 had tested positive for RSV and 10 yielded a PCR product of the expected size in the RT-PCR assay (Fig. 3) . No PCR products were detected when the 11 RSV-negative NPAs were similarly analyzed (Fig. 4) obtained from the undiluted RSV-infected cell culture extract used as a positive control.
DISCUSSION
In a previous study (1), we have shown that PCR is a very promising method for the rapid detection of a bacterial respiratory pathogen (Bordetella pertussis) in NPAs. The PCR test for pertussis is very sensitive, particularly since the target sequence for amplification is reiterated approximately 100 times per genome. In the present study, we have sought to determine whether PCR methodology can also be applied to direct detection of viral respiratory pathogens, particularly pathogens such as RSV which have an RNA genome, thereby necessitating RT before the PCR amplification step. Rapid detection of RSV is of great clinical importance in a pediatric hospital, because it is a major cause of nosocomial infection; also, antiviral therapy is effective against this pathogen (9) . The RSV culture procedure used by the central pathology laboratory is extremely sensitive, because it involves testing of cell cultures for virus infection by EIA and examination for cytopathic effect. However, this is a slow procedure; in the present study, it took from 3 to 13 days (median, 7 days) from collection of the NPA to produce a result. This time lag is greater than the mean bed stay of patients with bronchiolitis (the most common RSV infection) at the Adelaide Children's Hospital (4.0 days), and so in the majority of cases the patient would have been discharged from the hospital before the culture result became available. Direct ETA, although yielding a result within 24 h, was of limited clinical value in these cases because of its low sensitivity (approximately 41%).
RT-PCR, on the other hand, was both sensitive and specific for RSV. When extracts of diluted RSV-infected cell cultures were tested, the RT-PCR assay was capable of detecting as few as 10 TCID50s, but negative results were FIG. 4. RT-PCR of culture-negative NPAs. Lanes: M, DNA size markers (as in the legend to Fig. 1) ; -, uninfected HEp-2 lysate; 1 to 11, culture-negative NPAs; +, RSV-infected HEp-2 lysate. The major advantage of RT-PCR over virus culture, however, is its speed; an RT-PCR result is available within 8 to 24 h, depending on the time of receipt of the specimen. Thus, RT-PCR is as rapid as the alternative direct detection procedure, EIA, but has vastly superior sensitivity to EIA. The clear outperformance of EIA by RT-PCR was unexpected, because it could be argued that the advantages of amplification of viral nucleic acid might be at least partially offset by the lability of the RNA in the NPA. Also, each virion contains a large number of EIA target molecules but only one RT-PCR target. Notwithstanding these considerations, the results of this study indicate that RT-PCR has great potential for the rapid diagnosis of RSV infection.
